 An open-label, long-term study to evaluate the safety of inhaled nitric oxide iNO in subjects with pulmonary arterial hypertension PAH who participated in IK-7001-PAH-201 and to provide these patients with continued access to chronic iNO until the time of approval or when the trial is discontinued due to lack of efficacy. 